The plasma levels of ANXA1 were about three-fold lesser in SCD patients compared to the control group, and within the SCD genotypes the most elevated levels were found in Hb SS individuals (approximately three-fold higher). This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.